ECP
Showing 1 - 25 of 268
High-Risk Percutaneous Coronary Intervention Trial (Impella ECP)
Recruiting
- High-Risk Percutaneous Coronary Intervention
- Impella ECP
-
Detroit, MichiganAscension St. John Hospital
Dec 23, 2022
Lung Transplant Infection, Lung Transplant Rejection Trial in Vienna (ECP (Extracorporeal Photopheresis System))
Completed
- Lung Transplant Infection
- Lung Transplant Rejection
- ECP (Extracorporeal Photopheresis System)
-
Vienna, AustriaMedical University Vienna
Jan 31, 2023
Intestinal Biomarker Analysis After ECP for ICI Colitis
Recruiting
- Colitis
- Immune Checkpoint Inhibitor-Related Colitis
- Intestinal tissue analysis
-
Freiburg, Baden Württemberg, GermanyFreiburg University Medical Center
Oct 5, 2023
Type 1 Diabetes Trial in Abu Dhabi (ECP regular-intensity arm, ECP accelerated-intensity arm, T1DM standard of care)
Recruiting
- Type 1 Diabetes
- ECP regular-intensity arm
- +2 more
-
Abu Dhabi, United Arab EmiratesAbu Dhabi Stem Cells Center
Oct 28, 2022
Chronic Graft-versus-host-disease Trial in Salt Lake City (Itacitinib, Extracorporeal Photopheresis (ECP))
Active, not recruiting
- Chronic Graft-versus-host-disease
- Itacitinib
- Extracorporeal Photopheresis (ECP)
-
Salt Lake City, UtahHuntsman Cancer Institute at University of Utah
Jan 30, 2023
High-risk Percutaneous Coronary Intervention Trial in Boston, Detroit, Cincinnati (Impella ECP)
Recruiting
- High-risk Percutaneous Coronary Intervention
- Impella ECP
-
Boston, Massachusetts
- +3 more
Jun 27, 2022
Extracorporeal Photopheresis in Sezary Syndrome
Recruiting
- Sezary Syndrome
- Extracorporeal photopheresis (ECP)
- Methoxsalen Injection
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Medical Center
Aug 12, 2022
Immune Related Adverse Events, Colitis, Hepatitis Trial in Freiburg (ECP)
Recruiting
- Immune Related Adverse Events
- +3 more
- ECP
-
Freiburg, Baden-Württemberg, GermanyMedical Center - University of Freiburg Albert-Ludwigs-Universit
Jun 9, 2022
Antibody-mediated Rejection, Lung Transplant Rejection Trial (Extracorporeal Photopheresis)
Not yet recruiting
- Antibody-mediated Rejection
- Lung Transplant Rejection
- Extracorporeal Photopheresis
- (no location specified)
Oct 30, 2023
Photopheresis in GvHD After Hematopoietic Transplantation:
Enrolling by invitation
- Graft Vs Host Disease
- Extracorporeal Photopheresis
- Extracorporeal Photopheresis
-
Roma, ItalyFondazione Policlinico Universitario Agostino Gemelli (FPG) - IR
Feb 7, 2023
Solid Tumor Trial in Guangzhou (ECP-1014)
Not yet recruiting
- Solid Tumor
-
Guangzhou, Guangdong, ChinaThe Sixth Affiliated Hospital Sun Yat-sen University
Jun 22, 2021
GVHD Trial in Oslo (Extracorporeal photophoresis (ECP))
Completed
- Graft-Versus-Host Disease
- Extracorporeal photophoresis (ECP)
-
Oslo, NorwayTobias Gedde-Dhl
Feb 14, 2022
GVHD Trial in Cleveland (Allogeneic mesenchymal stromal cells (MSCs), Extracorporeal photopheresis (ECP))
Not yet recruiting
- Graft Versus Host Disease
- Allogeneic mesenchymal stromal cells (MSCs)
- Extracorporeal photopheresis (ECP)
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Nov 14, 2022
Counterpulsation, Angina Pectoris Trial in Bandung (External Counter Pulsation (ECP) therapy)
Not yet recruiting
- Counterpulsation
- Angina Pectoris
- External Counter Pulsation (ECP) therapy
-
Bandung, West Java, IndonesiaDr. Hasan Sadikin General Hospital
May 5, 2021
Kidney Transplantation Trial (Extracorporeal phototherapy)
Not yet recruiting
- Kidney Transplantation
- Extracorporeal phototherapy
- (no location specified)
Apr 28, 2021
Folliculotropic Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome Trial in Duarte (procedure,
Active, not recruiting
- Folliculotropic Mycosis Fungoides
- +7 more
- Extracorporeal Photopheresis
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Dec 8, 2022
Chronic GVHD Trial in Duarte (biological, procedure, other)
Active, not recruiting
- Chronic Graft Versus Host Disease
- Aldesleukin
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 4, 2023
ECP Combination Study
Active, not recruiting
- Steroid Refractory GVHD
- Ruxolitinib
- +2 more
-
Antwerp, Belgium
- +37 more
Jun 17, 2022
Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome Trial in Atlanta (procedure, biological,
Recruiting
- Mycosis Fungoides
- +2 more
- Extracorporeal Photopheresis
- +2 more
-
Atlanta, GeorgiaEmory University Hospital
Jun 15, 2022
Asthma Trial in Tampere (Peripheral exhaled nitric oxide)
Recruiting
- Asthma
- Peripheral exhaled nitric oxide
-
Tampere, FinlandAllergy Centre, Tampere University Hospital
Oct 18, 2021
Graft Vs Host Disease Trial in Toronto (Drug or biologic - anti-thymocyte globulin (ATG), extracorporeal photopheresis (ECP),
Recruiting
- Graft Vs Host Disease
- Drug or biologic - anti-thymocyte globulin (ATG), extracorporeal photopheresis (ECP), mTOR inhibitors (everolimus or sirolimus), vedolizumab, ruxolitinib.
- Decidual Stromal Cells
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Feb 3, 2022
Normal Tension Glaucoma, Cataract Trial in Helsinki (Phaco, Phaco+ECP)
Recruiting
- Normal Tension Glaucoma
- Cataract
- Phaco
- Phaco+ECP
-
Helsinki, FinlandHelsinki University Hospital
Dec 18, 2020
GVHD, Acute Trial in Denmark, Norway, Sweden (Decidua Stroma Cells (DSC), Best available Treatment (BAT))
Recruiting
- GVHD, Acute
- Decidua Stroma Cells (DSC)
- Best available Treatment (BAT)
-
Copenhagen, Denmark
- +5 more
Sep 30, 2021
Glaucoma, Angle-Closure Trial in Riyadh (Phacoemulsification, Endoscopic cyclophotocoagulation)
Unknown status
- Glaucoma, Angle-Closure
- Phacoemulsification
- Endoscopic cyclophotocoagulation
-
Riyadh, Saudi ArabiaKing Khaled Eye Specialist Hospital
Sep 18, 2020